Kiora Pharmaceuticals logo

Kiora Pharmaceuticals Share Price Today

(NASDAQ: KPRX)

Kiora Pharmaceuticals share price is $3.17 & ₹275.69 as on 6 Mar 2025, 2.30 'hrs' IST

$3.17

0.22

(7.46%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Kiora Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Kiora Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Kiora Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Kiora Pharmaceuticals share price movements

  • Today's Low: $2.95
    Today's High: $3.17

    Day's Volatility :6.94%

  • 52 Weeks Low: $2.92
    52 Weeks High: $6.48

    52 Weeks Volatility :55.0%

Kiora Pharmaceuticals (KPRX) Returns

PeriodKiora Pharmaceuticals IncIndex (Russel 2000)
3 Months
-15.38%
0.0%
6 Months
-16.19%
0.0%
1 Year
-53.17%
0.0%
3 Years
-98.49%
-11.6%

Kiora Pharmaceuticals (KPRX) Key Statistics

in dollars & INR

Previous Close
$2.95
Open
$2.91
Today's High
$3.17
Today's Low
$2.95
Market Capitalization
$10.8M
Today's Volume
$916.0
52 Week High
$6.48
52 Week Low
$2.916
Revenue TTM
$16.0M
EBITDA
$6.3M
Earnings Per Share (EPS)
$16.53
PE Ratio
0.22
Profit Margin
19.98%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
13.69%

How to invest in Kiora Pharmaceuticals Stock (KPRX) from India?

It is very easy for Indian residents to invest directly in Kiora Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Kiora Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Kiora Pharmaceuticals or KPRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Kiora Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Kiora Pharmaceuticals shares which would translate to 0.274 fractional shares of Kiora Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Kiora Pharmaceuticals, in just a few clicks!

Returns in Kiora Pharmaceuticals (KPRX) for Indian investors in Rupees

The Kiora Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Kiora Pharmaceuticals investment value today

Current value as on today

₹55,280

Returns

₹44,720

(-44.72%)

Returns from Kiora Pharmaceuticals Stock

₹49,683 (-49.68%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Kiora Pharmaceuticals (KPRX)

-74%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Kiora Pharmaceuticals Stock from India on INDmoney has decreased by -74% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Kiora Pharmaceuticals

  • AIGH Capital Management, LLC

    8.52%

  • Rosalind Advisors, Inc.

    8.35%

  • Nantahala Capital Management, LLC

    7.04%

  • Stonepine Capital Management Llc

    6.70%

  • ADAR1 Capital Management LLC

    6.67%

  • Velan Capital Investment Management LP

    4.07%

Analyst Recommendation on Kiora Pharmaceuticals

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Kiora Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Kiora Pharmaceuticals Stock (KPRX)

What analysts predicted

Upside of 856.78%

Target:

$30.33

Current:

$3.17

Insights on Kiora Pharmaceuticals Stock (Ticker Symbol: KPRX)

  • Price Movement

    In the last 3 years, KPRX stock has moved down by -98.6%
  • KPRX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 113.3%
  • KPRX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 146.3%
  • Price to Sales

    ForKPRX every $1 of sales, investors are willing to pay $0.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Kiora Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Kiora Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Kiora Pharmaceuticals (KPRX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Kiora Pharmaceuticals Inc logo
-22.98%
-16.19%
-53.17%
-98.49%
-99.55%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Kiora Pharmaceuticals Inc logo
0.22
0.22
NA
1.35
0.14
0.13
NA
7.14
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Kiora Pharmaceuticals Inc logo
Buy
$10.8M
-99.55%
0.22
19.98%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Kiora Pharmaceuticals

Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 2 clinical trials indicated for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. The company is also developing KIO-104, a non-steroidal, immuno-modulatory, small-molecule inhibitor of dihydroorotate dehydrogenase, currently under phase 1b/2a study for the treatment of posterior non-infectious uveitis, as well as under pre-clinical development for the treatment of proliferative vitreoretinopathy; KIO-101, an eye drop for the treatment of ocular presentation of rheumatoid arthritis; and KIO-201, an eye drop for treating patients undergoing photorefractive keratectomy (PRK) surgery for corneal wound repair. It has commercialization agreement with 4SC Discovery GmbH, for KIO-101; and collaboration agreement with Théa Open Innovation for the development KIO-301. The company was formerly known as Eyegate Pharmaceuticals, Inc. and changed its name to Kiora Pharmaceuticals, Inc. in November 2021. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Encinitas, California.
Organization
Kiora Pharmaceuticals
Employees
12
CEO
Dr. Brian M. Strem Ph.D.
Industry
Miscellaneous

Management People of Kiora Pharmaceuticals

NameTitle
Dr. Brian M. Strem Ph.D.
President, CEO & Director
Ms. Melissa Tosca CPA
Chief Financial Officer
Dr. Eric J. Daniels M.B.A., M.D.
Chief Development Officer
Dr. Stefan Sperl Ph.D.
Executive Vice President of CMC & Operations

Important FAQs about investing in KPRX Stock from India :

What is Kiora Pharmaceuticals share price today?

Kiora Pharmaceuticals share price today stands at $3.17, Open: $2.91 ; Previous Close: $2.95 ; High: $3.17 ; Low: $2.95 ; 52 Week High: $6.48 ; 52 Week Low: $2.92.

The stock opens at $2.91, after a previous close of $2.95. The stock reached a daily high of $3.17 and a low of $2.95, with a 52-week high of $6.48 and a 52-week low of $2.92.

Can Indians buy Kiora Pharmaceuticals shares?

Yes, Indians can invest in the Kiora Pharmaceuticals (KPRX) from India.

With INDmoney, you can buy Kiora Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Kiora Pharmaceuticals at zero transaction cost.

How can I buy Kiora Pharmaceuticals shares from India?

It is very easy to buy Kiora Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Kiora Pharmaceuticals (KPRX) be purchased?

Yes, you can buy fractional shares of Kiora Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Kiora Pharmaceuticals stocks?

To start investing in Kiora Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Kiora Pharmaceuticals Stock (KPRX)?

Today’s highest price of Kiora Pharmaceuticals (KPRX) is $3.17.

Today’s lowest price of Kiora Pharmaceuticals (KPRX) is $2.95.

What is today's market capitalisation of Kiora Pharmaceuticals?

Today's market capitalisation of Kiora Pharmaceuticals KPRX is 10.8M

What is the 52 Week High and Low Range of Kiora Pharmaceuticals Stock (KPRX)?

  • 52 Week High

    $6.48

  • 52 Week Low

    $2.92

What are the historical returns of Kiora Pharmaceuticals (KPRX)?

  • 1 Month Returns

    -22.98%

  • 3 Months Returns

    -16.19%

  • 1 Year Returns

    -53.17%

  • 5 Years Returns

    -99.55%

Who is the Chief Executive Officer (CEO) of Kiora Pharmaceuticals ?

Dr. Brian M. Strem Ph.D. is the current Chief Executive Officer (CEO) of Kiora Pharmaceuticals.